Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,581 | 70,495 | 55,034 | 43,163 | 50,646 |
| Marketable Securities | 140,753 | 156,485 | 157,735 | 154,710 | 142,778 |
| Receivables | 48,315 | 50,365 | 44,821 | 44,285 | 43,583 |
| Inventories | 11,206 | 9,820 | 9,933 | 8,403 | 8,684 |
| TOTAL | $291,807 | $300,185 | $281,435 | $261,856 | $256,489 |
| Non-Current Assets | |||||
| PPE Net | 30,774 | 34,107 | 37,498 | 41,055 | 44,430 |
| Investments And Advances | 18,889 | 13,234 | 4,037 | 24,100 | 39,355 |
| Intangibles | 120,279 | 120,698 | 121,127 | 121,555 | 121,978 |
| Other Non-Current Assets | 44,194 | 44,512 | 46,513 | 48,071 | 48,600 |
| TOTAL | $214,136 | $212,551 | $209,175 | $234,781 | $254,363 |
| Total Assets | $505,943 | $512,736 | $490,610 | $496,637 | $510,852 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,615 | 6,467 | 10,267 | 6,908 | 6,362 |
| Accrued Expenses | 13,682 | 24,692 | 19,886 | 16,905 | 14,169 |
| Other current liabilities | 5,804 | 4,642 | 2,429 | 3,070 | 2,011 |
| TOTAL | $87,011 | $89,915 | $83,361 | $92,141 | $87,809 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 49,397 | 45,194 | 41,337 | 55,301 | 54,805 |
| Other Non-Current Liabilities | 193,866 | 196,814 | 201,791 | 204,907 | 207,986 |
| TOTAL | $194,691 | $197,820 | $202,996 | $224,960 | $232,822 |
| Total Liabilities | $281,702 | $287,735 | $286,357 | $317,101 | $320,631 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,044 | 153,982 | 152,665 | 152,274 | 151,917 |
| Common Shares | 16 | 15 | 15 | 15 | 15 |
| Retained earnings | -1,383,356 | -1,363,323 | -1,349,744 | -1,359,290 | -1,333,676 |
| Other shareholders' equity | 7,873 | 6,461 | 29 | -108 | -68 |
| TOTAL | $224,241 | $225,001 | $204,253 | $179,536 | $190,221 |
| Total Liabilities And Equity | $505,943 | $512,736 | $490,610 | $496,637 | $510,852 |